D.L. Carlson Investment Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
D.L. Carlson Investment Group's DGX Position: Q2 2024 in Review
D.L. Carlson Investment Group sold out of Quest Diagnostics (DGX) in Q2 2024, closing a stake of 7,073 shares — an estimated $941K sold.
D.L. Carlson Investment Group first reported a position in DGX in Q3 2019 and held it in 19 quarters. The position peaked at $4.88M in Q2 2020. 838 funds tracked by Wall St. Rank hold DGX as of Q2 2024.
- D.L. Carlson Investment Group reported no remaining Quest Diagnostics position as of Q2 2024 after selling out during the quarter.
- D.L. Carlson Investment Group sold 7,073 Quest Diagnostics shares in Q2 2024, an estimated $941K.
- D.L. Carlson Investment Group first reported a position in Quest Diagnostics in Q3 2019 and held it in 19 quarters.
- D.L. Carlson Investment Group's Quest Diagnostics position peaked at $4.88M in Q2 2020.
- 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.
Based on D.L. Carlson Investment Group's 13F filing for Q2 2024, filed 14 Aug 2024.